Manabu Kitazawa

This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 4 EPO patents. Top assignee: Ajinomoto Co., Ltd.. Active years: 1997-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manabu Kitazawa. Retrieved from https://idiyas.com/inventor/manabu-kitazawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 5)

% Patents Active = 73.7

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 126(Granted Patents)

Company Filing History:

19 out of 1,953

Ajinomoto Co., Ltd.

patents

Years Active: 1997-2024

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11859205 - Medium for culturing stem cells (2024-01-02),

2. 10745669 - Culture method for stable proliferation of pluripotent stem cell while maintaining undifferentiated state (2020-08-18),

3. 10689622 - Culture medium for proliferating stem cell, which contains sulfated compound (2020-06-23),

4. 10662411 - Culture method for stable proliferation of pluripotent stem cell while maintaining undifferentiated state (2020-05-26),

5. 10457911 - Medium for stem cell use (2019-10-29),

6. 9890359 - Culture medium for proliferating stem cell, which contains sulfated compound (2018-02-13),

7. 9786450 - Membrane switch and object employing same (2017-10-10),

8. 9464167 - Poly α-amino acid and ferroelectric memory element using same (2016-10-11),

9. 9450174 - Piezoelectric element (2016-09-20),

10. 9192624 - Medical material and method for manufacturing same (2015-11-24),

11. 7879863 - Aniline derivatives (2011-02-01),

12. 7105570 - Cysteine derivatives (2006-09-12),

13. 6914075 - Cystine derivative and agent for suppressing activation of inflammatory factors (2005-07-05),

14. 6703031 - Cysteine derivatives (2004-03-09),

15. 6602492 - Cysteine derivatives (2003-08-05),

Title: The Innovative Mind of Manabu Kitazawa

Introduction: Manabu Kitazawa, located in Kawasaki, Japan, is an influential inventor in the realm of stem cell research. With a remarkable portfolio comprising 19 patents, his contributions significantly advance the methods and mediums used in cultivating stem cells.

Latest Patents: Among Manabu's most recent innovations are two notable patents. The first focuses on a culture medium for stem cells, which utilizes albumin with a reduced amount of fatty acid, proving beneficial for stem cell cultivation. His second patent introduces an efficient culture method for the stable proliferation of pluripotent stem cells while preserving their undifferentiated state, utilizing a medium that incorporates specific compounds such as ethanolamine, while minimizing or eliminating the presence of β-mercaptoethanol.

Career Highlights: Manabu Kitazawa has dedicated his professional career to enhancing the field of biotechnology through his role at Ajinomoto Co., Ltd. His extensive work in stem cell cultivation is recognized globally, contributing to the growing landscape of regenerative medicine and biopharmaceuticals.

Collaborations: Throughout his career, Manabu has worked alongside esteemed colleagues, including Keiji Iwasaki and Satoru Ohashi. Their combined expertise helps drive innovation and pushes the boundaries of their research towards impactful solutions in health and medicine.

Conclusion: Manabu Kitazawa's impressive accomplishments in patenting innovative techniques and materials for stem cell research underscore his role as a leading inventor in the field. His work not only facilitates advancements in stem cell technology but also inspires future developments in regenerative medicine.

Profile summary based on public USPTO records.